Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study
Titel:
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE—a global phase III study
Auteur:
Yoshino, T. Portnoy, D.C. Obermannová, R. Bodoky, G. Prausová, J. Garcia-Carbonero, R. Ciuleanu, T. García-Alfonso, P. Cohn, A.L. Van Cutsem, E. Yamazaki, K. Lonardi, S. Muro, K. Kim, T.W. Yamaguchi, K. Grothey, A. O’Connor, J. Taieb, J. Wijayawardana, S.R. Hozak, R.R. Nasroulah, F. Tabernero, J.